The Foundation for Angelman Syndrome Therapeutics (FAST) is the leading patient advocacy organization working to cure Angelman syndrome. As the largest non-governmental funder of Angelman syndrome research in the world, our goal is to drive forward transformative research and development programs as quickly as possible for those living with Angelman syndrome — regardless of age or genotype. At the core of FAST's mission is a commitment to bring scientific and therapeutic advancements from bench side to bedside, as quickly and safely as possible. To do so, FAST funds projects at every step in the trajectory of drug development, and we are as dedicated to nurturing promising ideas at their earliest stages as we are to protecting and advancing those that have already shown value. Apply for a grant today. All grant applications are considered on a rolling basis. We move fast so you can too. Learn More: https://cureangelman.org/apply-for-a-grant